BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29406185)

  • 21. RNF111/Arkadia is regulated by DNA methylation and affects TGF-β/Smad signaling associated invasion in NSCLC cells.
    Chen H; Yang T; Lei Z; Wang L; Yang H; Tong X; Yang WT; Zhao J; Gu Y; Chen Y; Zhang HT
    Lung Cancer; 2015 Oct; 90(1):32-40. PubMed ID: 26238425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OPN-a Splicing Variant Expression in Non-small Cell Lung Cancer and its Effects on the Bone Metastatic Abilities of Lung Cancer Cells
    Hao C; Cui Y; Hu MU; Zhi X; Zhang L; Li W; Wu W; Cheng S; Jiang WG
    Anticancer Res; 2017 May; 37(5):2245-2254. PubMed ID: 28476789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arctigenin represses TGF-β-induced epithelial mesenchymal transition in human lung cancer cells.
    Xu Y; Lou Z; Lee SH
    Biochem Biophys Res Commun; 2017 Nov; 493(2):934-939. PubMed ID: 28951214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8.
    Zhang Z; Zhang L; Yin ZY; Fan XL; Hu B; Wang LQ; Zhang D
    Int J Clin Exp Pathol; 2014; 7(10):7236-41. PubMed ID: 25400821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cells.
    Ma Y; Kang S; Wu X; Han B; Jin Z; Guo Z
    Tumori; 2018 Oct; 104(5):338-343. PubMed ID: 28885675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
    Gao J; Meng Q; Zhao Y; Chen X; Cai L
    BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
    Zhang Y; Zhang Q; Chen H; Wang C
    Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.
    Li Y; Hu T; Chen T; Yang T; Ren H; Chen M
    Oncol Rep; 2018 Feb; 39(2):565-572. PubMed ID: 29207165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits migration and invasion through Epithelial-Mesenchymal-Transition in lung cancer.
    Hao Y; Yang X; Zhang D; Luo J; Chen R
    Gene; 2017 Apr; 608():1-12. PubMed ID: 28119085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2.
    Xu G; Yu H; Shi X; Sun L; Zhou Q; Zheng D; Shi H; Li N; Zhang X; Shao G
    BMC Pulm Med; 2014 Nov; 14():174. PubMed ID: 25380840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leptin promotes metastasis by inducing an epithelial-mesenchymal transition in A549 lung cancer cells.
    Feng H; Liu Q; Zhang N; Zheng L; Sang M; Feng J; Zhang J; Wu X; Shan B
    Oncol Res; 2013; 21(3):165-71. PubMed ID: 24512731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. trans-3-Methoxy-5-hydroxystilbene (MHS) from the rhizome of Alpinia nantonensis inhibits metastasis in human lung cancer cells.
    Kumar KJS; Wang SH; Tseng YH; Tsao NW; Kuo YH; Wang SY
    Phytomedicine; 2018 Nov; 50():223-230. PubMed ID: 30466982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Terfenadine combined with epirubicin impedes the chemo-resistant human non-small cell lung cancer both in vitro and in vivo through EMT and Notch reversal.
    An L; Li DD; Chu HX; Zhang Q; Wang CL; Fan YH; Song Q; Ma HD; Feng F; Zhao QC
    Pharmacol Res; 2017 Oct; 124():105-115. PubMed ID: 28754458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decitabine reverses TGF-β1-induced epithelial-mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis.
    Zhang N; Liu Y; Wang Y; Zhao M; Tu L; Luo F
    Drug Des Devel Ther; 2017; 11():969-983. PubMed ID: 28405157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
    Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
    Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of ethanol extract of Ocimum sanctum on osteopontin mediated metastasis of NCI-H460 non-small cell lung cancer cells.
    Kwak TK; Sohn EJ; Kim S; Won G; Choi JU; Jeong K; Jeong M; Kwon OS; Kim SH
    BMC Complement Altern Med; 2014 Oct; 14():419. PubMed ID: 25345853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
    Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-beta1 pathway.
    Lee HT; Chen SW; Doetschman TC; Deng C; D'Agati VD; Kim M
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F128-36. PubMed ID: 18434384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-β-induced miR‑143 expression in regulation of non-small cell lung cancer cell viability and invasion capacity in vitro and in vivo.
    Cheng T; Hu C; Yang H; Cao L; An J
    Int J Oncol; 2014 Nov; 45(5):1977-88. PubMed ID: 25175415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.
    Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT
    Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.